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Coumarin-Tagged Dinuclear Trithiolato-Bridged Ruthenium
(II)·Arene Complexes: Photophysical Properties and
Antiparasitic Activity
Oksana Desiatkina,[a] Emilia Păunescu,*[a] Martin Mösching,[a] Nicoleta Anghel,[b]
Ghalia Boubaker,[b] Yosra Amdouni,[b] Andrew Hemphill,*[b] and Julien Furrer*[a]
The synthesis, characterization, photophysical and biological
properties of 13 new conjugate coumarin-diruthenium(II)·arene
complexes against Toxoplasma gondii are presented. For all
conjugate organometallic unit/coumarins, an almost complete
loss of fluorescence efficacy was observed. However, the nature
of the fluorophore, the type of bonding, the presence and
length of a linker between the coumarin dye and the
ruthenium(II) moiety, and the number of dye units influenced
their biological properties. The in vitro activity against a trans-
genic T. gondii strain grown in human foreskin fibroblasts (HFF)
leads to IC50 values for T. gondii β-gal from 105 to 735 nM. Of
note is that nine compounds displayed lower IC50 than the
standard drug pyrimethamine. One compound applied at its
IC50 did not affect B-cell proliferation but had an impact on T-
cell proliferation in murine splenocyte cultures. Transmission
electron microscopy of T. gondii β-gal-infected HFF showed that
treatment predominantly affected the parasites’ mitochondrion.
Introduction
The use of ruthenium complexes as potential chemotherapeu-
tics has been an active area of research for almost two
decades.[1–3] Developed initially as a potential alternative to
platinum-based anticancer drugs,[4,5] ruthenium(II)·arene com-
plexes were also considered for other pharmacological proper-
ties, particularly as antiparasitic[6–13] and antibacterial
compounds.[14–17] A special class of ruthenium(II)·arene com-
plexes is constituted by symmetric[18,19] and “mixed”[20] cationic
trithiolato-bridged dinuclear ruthenium(II)·arene complexes
(general formulae [(η6-arene)2Ru2(μ2-SR)3]
+ and [(η6-are-
ne)2Ru2(μ2-SR
1)2(μ2-SR
2)]+, respectively). The high cytotoxicity
against human cancer cells shown by this type of compounds
and, more interestingly, their apparent ability to circumvent
platinum-drug resistance,[21] encouraged the development of
several libraries of complexes containing this scaffold as
potential biological active compounds. For example, IC50 values
as low as 30 nM against A2780 (human ovarian cancer) cells
and also against their cisplatin-resistant variant A2780cisR were
measured for compounds B and C (Figure 1), whereas the less
lipophilic complex A exhibited lower cytotoxicity (IC50 of 130
and 80 nM on A2780 and A2780cisR, respectively).
The mechanisms by which these trithiolato dinuclear
ruthenium complexes exert their cytotoxicity are still not clearly
determined. Due to their lipophilic nature, these trithiolato
dinuclear ruthenium complexes are only sparingly soluble in
water. In contrast, the diruthenium trithiolato moiety is stable,
neither hydrolyzing nor interacting with biomolecules such as
amino acids (other than cysteine), nucleotides, or glucose.[21]
This inertness towards hydrolysis and ligand substitution can be
attributed to the lack of the typical very labile RuIICl bonds or
carboxylate ligands that are present in many other RuII·arene
complexes. Nevertheless, weak binding to various proteins
(human serum albumin, (HsA), transferrin (Tf), cytochrome c
(Cyt c), ubiquitin (Ub), and myoglobin (Mb)) was demonstrated,
albeit through hydrogen bonds and π–π interactions and not
through covalent bonds.[21] Interestingly, catalytic oxidation of
bio-relevant reducing agents including cysteine and glutathione
(GSH) to form cystine and GSSG, respectively, was
demonstrated.[22] Although no correlation between the in vitro
cytotoxicity and the catalytic activity on the oxidation reaction
of glutathione could be observed,[19,22] it is nevertheless
considered that this process can be at least partially responsible
for the decreased cancer cell survival.
Recently, inductively coupled plasma mass spectrometry
(ICP-MS) showed that complexes A and C specifically target the
mitochondrion in A2780 (human ovarian cancer) cells, with up
to 97% of the Ru content being found in the mitochondrial
fraction.[23] Complex C was taken up by A2780 cells more
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efficiently than A, which parallels with the respective lip-
ophilicity of the two compounds.
Lately, trithiolato diruthenium compounds were reported to
exhibit interesting antiparasitic properties against Toxoplasma
gondii,[24] Neospora caninum[23] and Trypanosoma brucei.[25] Thus,
complex A presents an IC50 value of 34 nM against the
apicomplexan parasite T. gondii cultured in human foreskin
fibroblast (HFF) monolayers,[24] while compound B exhibits an
IC50 of 4 nM against T. brucei bloodstream forms.
[25] Viability of
uninfected HFF cells treated with 2.5 μM of complex A was
decreased to 63%, however complex B did not affect the vitality
when applied at the same concentration.[24] In Toxoplasma,
Neospora and in Trypanosoma, transmission electron micro-
scopy (TEM) demonstrated that trithiolato diruthenium com-
pounds affected the structural integrity of the mitochondrion
after few hours of treatment, and led to a more pronounced
destruction of tachyzoites at later timepoints.[24] In T. brucei,
these compounds altered the mitochondrial membrane poten-
tial, while other organelles and structural elements of the
parasites remained largely unaffected.[25]
The intracellular fate of these trithiolato dinuclear ruthe-
nium complexes, and how they exert anticancer and antipar-
asitic effects, are unknown, and thus investigating their cellular
traffic and possible mechanisms of action has become a priority.
In vitro/in vivo tracking of organometallic drugs using traceable
compounds represents a promising approach.[26,27] Various
conjugates obtained by anchoring an imaging probe to the
biologically active metal-organic moiety were shown to facili-
tate the intracellular tracing of the metal-based drugs.[28–30]
However, the modification of a drug with a fluorophore tag can
strongly influence its physicochemical properties, and thus
activity and behavior. It was already shown that anchoring
different fluorophores (coumarin, BODIPY, porphyrin) on the
same therapeutic organometallic moiety influences cellular
internalization and accumulation.[28–30] Thus, the optimization of
the conjugate structure (the organometallic drug onto which
the fluorophore probe is already anchored/tethered) should be
considered from the beginning.
Microscopy studies of BODIPY,[29,31] coumarin[32] and
naphthalimide[33]-tagged ruthenium conjugates demonstrated
that these conjugates could be applied for investigating the
subcellular localization of half-sandwich ruthenium(II)·arene
complexes. Due to their good photophysical properties, chem-
ical stability, and ease of synthetic modifications, coumarin
derivatives represent an important class of fluorescent probes
for biological imaging.[34,35] Additionally, compounds presenting
a coumarin scaffold display broad pharmacological activities
and their potential as anticancer agents has received a lot of
interest.[36–40]
In the particular case of traceable organometallic drugs, two
strategies can be considered: 1) direct coordination of the
(coumarin) fluorophore to the metal center[41,42] or 2) anchoring
of the dye to more elaborated ligands.[32,43, 44] The nature of the
metal center as well as the type of the ligand can strongly affect
the photophysical properties of the hybrid molecule. Some data
on the development of trackable anticancer agents based on
metal complexes were recently reviewed.[26,45] Conjugates
combining metalorganic units with covalently linked coumarins
have been shown to be versatile tools for imaging in the case
of various fluorophore-tagged platinum,[43,44, 46] ruthenium,[32]
gold[28,47, 46] or iridium[48] complexes. Some examples of coumarin
modified organometallic compounds are presented in Figure 2.
Coumarin-tagged ruthenium(II)·arene complex D was shown
to be useful for bioimaging.[32] Laser scanning confocal micro-
scope (LSCM) showed that compound D was internalized by
HCT-116 cells (human colorectal cancer, IC50=66 μM), causing
intracellular fluorescence after 3 h of incubation when applied
at 30 μM. The process occurred in a concentration-dependent
manner. Similar results were obtained with PtIV conjugate E,[44]
which was considered as potential tracking agent due to the
presence of a coumarin moiety. Nevertheless, neither for
conjugate D nor E were physical properties (in terms of
fluorescence quantum yield ΦF) reported.
Compound F is a three-in-one hybrid containing both an
androgen receptor (AR) binding ligand and a coumarin unit
connected to a PtIV moiety.[46] The fluorescence quantum yield
of F was weaker than that of the respective coumarin ligand
(ΦF=0.072 vs 0.32). F was effectively internalized and visualized
by LSCM in LNCaP (AR+) cells (androgen-sensitive human
prostate adenocarcinoma cells overexpressing androgen recep-
tor) after 4 h of incubation when applied at 20 μM. Derivative G,
a PtII complex of a coumarin modified diethylenetriamine, was
Figure 1. Structure of cationic trithiolato diruthenium(II)·arene complexes presenting high cytotoxicity against cancer cells and efficacy against various
parasites.
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developed as a selective probe, fluorescent agent and inorganic
medicinal agent.[43] However, the fluorescence intensity of the
coumarin moiety was reduced by 90% in this conjugate, thus
no microscopy studies on cellular uptake were reported. Several
gold(I) complexes bearing coumarin units were described.[28,47,49]
For example gold(I) carbene complex H displayed poor photo-
physical properties (fluorescence quantum yield, ΦF=2%), the
fluorescence quenching being attributed to a photo-induced
electron transfer between the coumarin and the carbene.[47]
Nevertheless fluorescence confocal microscopy demonstrated
the uptake of H in the nuclei of A2780 (human ovarian cancer)
cells (IC50=12 μM) at a concentration of 50 μM. In contrast,
gold(I) phosphine complex I showed interesting photophysical
properties (ΦF=83%), and two-photon fluorescence micro-
scopy of MDA-MB-231 (human breast adenocarcinoma) cells
showed this compounds to accumulate at the plasma mem-
brane as small aggregates.[28] Interestingly, reports on coumarin
trithiolato decorated compounds such as J[18,50] focused only on
the anticancer activity of the compounds and not on their
photophysical properties.
The easy synthesis of symmetric and mixed trithiolato
dinuclear ruthenium complexes presenting functional groups
that further allow “chemistry on the complex” opens the
possibility to prepare various conjugates with the molecules of
interest, for example, fluorophores, drugs, or biomolecules
(amino acids, fatty acids, polyamines, carbohydrates). Hybrid
molecules with anticancer drug chlorambucil[51] and short
peptides[52] were already reported as potential strategy to
enhance the anticancer activity.
Herein, we report the design and synthesis of a library of
new trithiolato-bridged dinuclear ruthenium(II)·arene organo-
metallic conjugates in which coumarin fluorophore moieties
were anchored as pendant arms on the bridge thiol(s). A
systematic assessment of the influence of various structural
features of the conjugates (nature of the fluorophore, type of
bonding (ester vs amide), presence and length of a linker
between the coumarin dye and the binuclear ruthenium(II)
moiety, number of dye units) upon the photophysical and
biological properties was performed. All compounds of interest
(coumarin-labeled conjugates, unmodified thiolato-bridged di-
nuclear ruthenium(II)·arene complexes and free dyes) were
evaluated with respect to their activity against the transgenic
strain T. gondii β-gal grown in HFF host cells. In addition, the
cytotoxicity in uninfected HFF was assessed. For selected
compounds, the potential to impair immunity was assessed
using B- and T-cell proliferation assays, and TEM was carried out
to evaluate structural alterations in treated parasites.
Results and Discussion
Synthesis and characterization of the compounds
In this study, the influence of various structural features of the
coumarin conjugates (nature of the fluorophore, type of
bonding (ester vs amide), presence and length of a linker/
spacer between the dye and the diruthenium moiety, number
of the fluorophore units) upon the photophysical and biological
properties was evaluated.
Coumarin derivatives present a wide structural diversity due
to the different substitution possibilities within their basic motif
that contains a benzene ring fused to an α-pyrone. Analogues
substituted with electron-donating groups in position 7 such as
7-methoxy and 7-diethylamino coumarins are frequently used
fluorophores. The two coumarin dyes considered for this study,
namely 7-(diethylamino)-2-oxo-2H-chromene-3-carboxylic acid
(Dye1-CO2H) and 11-oxo-2,3,6,7-tetrahydro-1H,5H,11H-pyrano
[2,3-f]pyrido[3,2,1-ij]quinoline-10-carboxylic acid (also known as
butterfly coumarin 343, Dye2-CO2H) present easy derivatizable
carboxylic group. The use of these particular fluorophores is
Figure 2. Structures of various organometallic moiety·coumarin conjugates.
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justified by their good quantum yields, appropriate absorption/
emission wavelengths (different emission colors), lipophilicity,
lack of net ionic charge, photostability, and relatively small
size.[34,35] It is well known that the photophysical properties of
the coumarin derivatives can be tuned with small changes in
the substituents and their position.[53] If these two coumarins
present very similar structure, previous reports associated the
blockage of the free rotation of the C  N bond in Dye2-CO2H,
which constrains the nitrogen lone pair to a maximal interaction
with the aromatic rings, with an improvement of the photo-
physical properties compared to Dye1-CO2H.
[54,55] Nevertheless,
if this interaction results in higher quantum yield in aqueous
solution for Dye2-CO2H than the diethylamino-coumarin Dye1-
CO2H, the coumarin substituent is more bulky and hydrophobic.
A SAR study[56] performed on a library of trithiolato-bridged
dinuclear ruthenium(II)·arene compounds showed that the
nature of the substituents in the para position of the other two
thiol ligands influence the biological properties of the com-
plexes. Some of the compounds were developed also in an
analogue series in which the bulky hydrophobic tBu substitu-
ents were replaced by hydrophobic polar CF3 groups, in order
to determine the role of this type of structural modifications
upon the biological activity of the conjugates.
The first series of compounds were functionalized with one
coumarin unit anchored to one of the bridged thiols, providing
a ratio metal-organic moiety: dye of 1 : 1. To access this type of
analogues, the previously reported[56] dinuclear trithiolato
ruthenium(II)·arene intermediates, bearing one hydroxy 2a/b,
amino 3a/b and carboxylic acid group 4a/b, were prepared
starting from the ruthenium dimer ([Ru(η6-p-MeC6H4iPr)Cl]2Cl2)
in two synthetic steps (Scheme 1).[20] Obtaining this type of
mixed trithiolato complexes is facilitated by the easy synthesis
of the dinuclear dithiolato intermediates 1a/b which were
isolated in high yields. In the case of the carboxylate
functionalized trithiolato complexes 4a/b a mixture of CH2Cl2/
acetone (10 :1, v/v) was used as solvent to avoid esterification
side reaction catalyzed by the hydrochloric acid resulted during
the reaction).
If intermediates 2a/b and 3a/b could be directly coupled
with the two dyes considered Dye1-CO2H and Dye2-CO2H
through ester or amide bonds, respectively (Scheme 3), the
carboxylate functionalized trithiolato complexes 4a/b offer the
possibility to introduce linkers of variable length between the
organometallic moiety and the dye. To this end, the linker
modified coumarins 8, 9 and 10 were synthesized in two steps
staring from the corresponding coumarins (Dye1-CO2H or
Dye1-CO2H) and the appropriate monoprotected diamine
(Scheme 2).
The coupling reactions of 2a/b and 3a/b with fluorophores
Dye1-CO2H and Dye2-CO2H afforded the ester 11, 12a/b and
amide 13, 14a/b conjugates in medium to good yields (65–
99%; Scheme 3). The coumarin hybrids 15, 16a/b and 17a/b
containing an amino spacer were obtained in reasonable yields
(12–69%) by reacting the carboxylate functionalized trithiolato
Scheme 1. Synthesis of the dinuclear dithiolato 1a/b and OH-, NH2-, CH2CO2H-functionalized trithiolato ruthenium(II)·arene intermediates 2a/b, 3a/b and 4a/
b.
Scheme 2. Synthesis of the coumarin precursors containing an amino spacer 8, 9 and 10.
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complexes 4a/b with the judiciously functionalized fluoro-
phores 8, 9 and 10 (Scheme 4). The esterification reactions were
realized using 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide
(EDCI) as coupling agent and 4-dimethylaminopyridine (DMAP)
as catalyst. For the amide bond formation, the coupling
reactions were conducted in the presence of 1-hydroxybenzo-
triazole (HOBt) and EDCI as coupling agents and N,N-diisopro-
pylethylamine (DIPEA) as basic catalyst. As previously reported
in other conjugation reactions run on the trithiolato diruthe-
nium complexes, the organometallic scaffold is stable to ligand
exchange in the reaction conditions used.[51,52]
A second family of conjugates with organometallic unit:
fluorophore (dye) ratios of 1 :2 and 1 :3 was also synthesized
(Scheme 5) and their photophysical and biological properties
were evaluated.
Conjugate 20 functionalized with two coumarin units was
synthesized in three steps starting from ([Ru(η6-p-MeC6H4Pr
i)
Cl]2Cl2). If the synthesis of the dithiolato intermediates 1a/b,
obtained by the complexation of less active benzylic thiols,
could be easily controlled by the judicious use of the reagents
ratio, the use of more reactive aromatic thiol of 4-mercaptophe-
nol led to complex mixture of the desired dithiolato product 18,
accompanied by trithiolato and monothiolato complexes, as
well as unreacted ruthenium dimer. Nevertheless, the next two
steps: 1) complexation of a third thiol with the obtainment of
mixed trithiolato compound 19 bearing two hydroxy groups,
and 2) subsequent esterification reaction with Dye1-CO2H
leading to dicoumarin conjugate 20 proceed smoothly, with
isolated yields of 96 and 75%, respectively (Scheme 5).
The trisubstituted conjugate 22 was obtained in two steps,
the synthesis of the symmetric trihydroxy intermediate 21
Scheme 3. Synthesis of the coumarin-based ester 11, 12a/b (top) and amide 13, 14a/b (bottom) conjugates.
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Scheme 4. Synthesis of the coumarin conjugates 15, 16a/b and 17a/b containing an amino spacer.
Scheme 5. Synthesis of conjugates 20 and 22 bearing two and three fluorophore units, respectively.
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(previously reported[57]) followed by the anchoring of three
coumarin dye units, and was isolated in good yield (61%).
All compounds were characterized by 1H, 19F (when
appropriate), and 13C NMR spectroscopy, mass spectrometry,
and elemental analysis (see the Supporting Information for full
details).
For example, the 1H NMR spectra of hydroxy 2a and amine
3a intermediates differ from those of the respective ester and
amide conjugates 11/12a and 13/14a. After anchoring the
coumarin unit via an ester bond, for 11 and 12a the two
protons in the α position to the ligand C  O are observed at
slightly lower frequencies, by about ΔδH �0.05 ppm, whereas
the protons in the β position with respect to the C  O bond are
shifted towards higher frequencies ΔδH �0.32 ppm. In the
13C
NMR spectra of esters 11 and 12a the corresponding C atoms α
to the ligand C  O are observed at higher frequencies than in
hydroxy intermediate 2a, ΔδC �5.6 ppm. Following esterifica-
tion, a strong effect is observed on the ligand C  O, which is
shifted to lower frequencies with ΔδC �8.6 ppm compared to
C  OH 2a. In the case of amides 13 and 14a, the signal
corresponding to the two protons in the α position to the
ligand C  NH are strongly shifted to higher frequencies, by
about ΔδH �0.96 ppm, whereas a similar but less important
effect of only ΔδH �0.25 ppm is observed in the case of the
corresponding protons in the β position with respect to the
C  NH. The 13C NMR spectra of amides 13 and 14a shows the C
atoms α to the ligand C  NH at higher frequencies than in
amine 3a with ΔδC �4.8 ppm. After amide bond formation, the
signal corresponding to the ligand C  NH is strongly shifted to
lower frequencies with ΔδC �9.6 ppm compared to the
respective signal/peak C  NH2 in compound 3a. Less important
shifts are observed in the 1H NMR spectra of amides 15, 16a
and 17a compared to acid intermediate 3a for the correspond-
ing protons α to the ligand C  CH2CONH due to the presence of
the methylene spacer.
Interesting, in the 1H NMR spectra of the di-hydroxy
intermediate 19 and of the diester 20, two sets of signals/peaks
corresponding to the two 4-mercaptophenolic ligands are
observed, indicating that they are not equivalent in the NMR
time scale measurement. Electrospray ionization mass spec-
trometry (ESI-MS) corroborated the spectroscopic data. The
spectra of the dithiolato intermediates contain a parent ion
peak attributable to the [M  Cl]+ ion, formed after the loss of
one of the labile chlorine ligands. The ESI-MS of the cationic
trithiolato complexes exhibit a strong peak corresponding to
[M  Cl]+ ion.
The compounds containing the trithiolato scaffold (inter-
mediates as well as conjugates) are stable towards ligand
exchange in highly complexing solvent as [D6]DMSO even after
elongated storage at 0 °C (see Figures S2–S4 in the Supporting
Information for the spectra corresponding to compounds 2a–
4a and 11–17a). This is essential to validate the biological tests
for which compounds are used as stock solutions in DMSO.
The solid-state structure of symmetric intermediate 21
containing three free hydroxy groups was established by single
crystal X-ray diffraction analysis (Figure 3), confirming the
expected molecular structure.
X-ray crystallography
The crystal structure of the symmetric complex 21 was
established in the solid state by single-crystal X-ray diffraction
(ORTEP representations shown in Figure 3), confirming the
expected structure. Selected bond lengths and angles are
presented in Table S2. Data collection and refinement parame-
ters are given in Table S1.
The Ru2S3 unit forms a trigonal-bipyramidal framework; no
metal–metal bond are present, the corresponding Ru(1)C  Ru(2)
distance being 3.341 Å. In the cation, the values of RuC  S
bonds as well as the RuC  SC  Ru angles (Table S2) are similar to
those found in other symmetric p-cymene derivatives reported
previously.[18]
In the network of 21 a complex interplay of H-bonding
interactions involving the chlorine anions and the three OH
groups of the complex in observed (Table S3). Each Cl  ion
interacts with the OH groups from three different cationic
complexes. A dimeric organization is saw, which is mediated by
four H-bonding interactions: two chlorine anions bridge two
diruthenium units at the level of their respective two hydroxy
groups (Figure S1). The remaining hydroxy group of each of the
symmetric diruthenium complexes is involved in H-bonding
interactions with another Cl  ion. Thus, all three hydroxy groups
of the symmetric trithiolato di-nuclear ruthenium(II)·arene
complex 21 are involved in intermolecular H-bonding inter-
actions, two of them interact with two chlorine anions and lead
to the formation of a dimer with another diruthenium unit,
whereas the third OH group interacts through H-bonds with
other Cl  anion present. In network these intermolecular H-
bonding interactions lead to further arrangements, for example,
with the formation of cycles involving up to four cationic
complexes.
Figure 3. ORTEP representation of complex 21 (thermal ellipsoids are 50%
equiprobability envelopes, and H atoms are spheres of arbitrary diameter;
the asymmetric unit contains also one CH2Cl2 molecule).
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Photophysical characterization
The photophysical properties of coumarin containing com-
pounds investigated in this study, namely the starting Dye1-
CO2H and Dye2-CO2H, coumarin-based amino intermediates 5–
7, and ester and amide conjugates with the trithiolato
ruthenium(II)-p-cymene scaffold 11–17a/b, 20 and 22, were
studied in CHCl3 and EtOH at room temperature and are
summarized in Tables 1 and S4. No solvatochromism was
observed. The absorption and emission spectra of representa-
tive compounds for 10 μM solutions in CHCl3 and/or EtOH are
comparatively presented in Figures 4, 5 and S5–S7.
The absorption spectra of all diruthenium unit/coumarin
conjugates 11–17a/b, 20 and 22 present a similar profile
(Figures 4, 5 and S5–S7). In both solvents, strong peaks
corresponding to the coumarin fragment are observed in the
410–460 nm region. The signals in the 200–300 nm range,
associated with the trithiolato dinuclear ruthenium(II)·arene
moiety, are better resolved in the spectra measured in CHCl3
compared to those in EtOH. For 11 and 12a/b, the direct
attachment of the trithiolato diruthenium moiety to coumarins
by ester bonds induced no shifts of the absorption peaks,
whereas in case of amides 13 and 14a/b a slight bathochromic
shift (Δλ �10 nm) was observed. In contrast, the presence of
the di-amino linker in conjugates 15–17a/b led to a slender
hypsochromic shift (Δλ �12–16 nm).
When excited at 405 nm, all coumarin-containing com-
pounds 5–17a/b, 20 and 22 emit in the blue range (450–
Table 1. Photophysical data of compounds 5–17a/b, 20 and 22 in CHCl3 at room temperature.
Compound labsmax [nm]
ɛ [M  1 cm  1] lemmax [nm] Δλ [nm] ΦF [%]
rhodamine 6G[a] 533 62696.6 557 24 75[a]
Dye1-CO2H 431 43074.2 458 27 184
Dye2-CO2H 449 47372.9 474 25 158
5 418.5 42971.9 449 30.5 186
6 417.5 47042.6 448 30.5 175
7 433.5 41504.7 463 29.5 170
11 431, 245 57147.6, 64027.8 455 24 4
12a 448, 245.5 59950.3, 64535.9 472 24 1
12b 447, 247.5 57647.7, 63481.4 474 27 0.4
13 439.5, 246 73039.4, 68176.6 458 18.5 0.3
14a 456, 245.5 68769.4, 62124.7 478 22 2
14b 454.5, 248 57340.8, 72892.3 480 25.5 2
15 418.5, 245.5 37245.8, 63190.6 454 35.5 3
16a 417, 245.5 39772.3, 65900.6 449 32 3
16b 417, 248 50370.3, 34021.4 449 32 2
17a 433.5, 245.5 36532.7, 64378.6 462 28.5 3
17b 433.5, 248 46995.0, 32315.8 465 31.5 3
20 431.5, 248.5 105690.0, 57402.0 457 25.5 0.3
22 432, 246 136190.0, 55390.8 459 27 0.4
[a] Values taken from ref. [58].
Figure 4. UV/Vis absorption (left) and emission (right) spectra of rhodamine 6G, Dye2-CO2H, intermediate 7, and the corresponding ester 12a and amide 14a,
17a conjugates at 10 μM in CHCl3.
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490 nm). The emission spectra of conjugates 11–17a/b,
presenting a 1 :1 ratio organometallic unit: coumarin, show
similar profiles (Figures 4, 5 and S5–S7) with almost complete
fluorescence quenching, only slightly less pronounced for
solutions in CHCl3 compared to those in EtOH. This loss of
fluorescence efficacy was independent of the nature of
coumarin (Dye1-CO2H or Dye2-CO2H), the type of bond (ester
or amide) or presence of a di-amino linker between the two
moieties. From this compound library, the highest calculated
fluorescence quantum yields remain very modest (ΦF �3%). Of
note, similar but less pronounced quenching effects were
observed in other organometallic coumarin-based conju-
gates.[26,32, 43]
For all coumarin conjugates (11–17a/b, 20 and 22) a small
bathochromic shift of the fluorescence maximum is observed in
EtOH compared to CHCl3 (Δλ �10 nm). The dramatic
fluorescence intensity change depending on the presence, or
not, of the trithiolato diruthenium unit could be valorized to
monitor the stability of the conjugates towards hydrolysis and
their behavior in vitro. Further structural optimization (as for
example the introduction of longer or more rigid spacers
between the diruthenium and fluorophore moieties) is required
in order for this type of conjugates to be used also as trackable
theranostics for the trithiolato di-nuclear ruthenium(II)·arene
fragment.
In the case of conjugates 20 and 22 with organometallic
moiety/dye ratios of 1 :2 and 1 :3, respectively, a proportional
increase was observed for the coumarin absorbance signal
(maximum at λ=431–432 nm), which parallels the number of
the attached dye units. No significant effect was observed for
the emission signal at 457–459 nm, corresponding to the
trithiolato diruthenium(II)·arene unit/moiety.
Coumarin intermediates 5–10 and conjugates bearing di-
amino linkers 15–17a/b present slightly larger Stokes shifts
compared to free Dye1-CO2H and Dye2-CO2H and other hybrid
molecules. Calculated Stokes shifts values range between 22–
36 nm for experiments performed using solutions in CHCl3, and
in 31–49 nm interval when EtOH was used as solvent.
In both solvents, CHCl3 and EtOH, a linear dependence of
the absorbance and emission intensity with concentration was
determined (data not shown). This is observed even in the case
of the conjugate 22 bearing three Dye1-CO2H units (spectra of
22 at various concentrations in CHCl3 are summarized in
Figure 6 and Figure S7).
Photostability
As the fluorescence intensity dramatically drops upon the
addition of the trithiolato diruthenium unit (coumarin–ruthe-
nium conjugates 11–17a/b, 20 and 22 compared to free Dye1-
CO2H and Dye2-CO2H), we used this difference to monitor the
stability of the hybrid molecules. To verify the compounds’
bleaching sensitivity but also stability at room temperature
under air, in the presence of a polar solvent that can induce
solvolysis, 10 μM solutions of 12b, 14b, 16b, 17b, 20 and 22 in
EtOH were maintained under indoor light for an extended time
period. Absorption and emission spectra were monitored after
24 h, 48 h, and one-week of light exposure, the measurements
being made in the same conditions as previously described.
Absorption spectra of all compounds remained unchanged after
48 h. After one week of light exposure a minor decrease of
intensity can be observed for the absorbance signal in the 350–
480 nm range, corresponding to the coumarin fragment.
In the emission spectra, notable changes were observed
only for ester conjugates 12b, 20, and 22 (data not shown). A
similar effect was noticed for the amide conjugates 14b and
17b (Figure 7), but only after one week of light exposure, while
Figure 5. UV/Vis absorption (left) and emission (right) spectra of rhodamine 6G, Dye2-CO2H, intermediate 7 and the corresponding ester 12b and amide 14b,
17b conjugates, at 10 μM in CHCl3.
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no spectral changes were observed for amide 16b. This increase
of the emission signal can be attributed to a partial solvolysis of
the ester or amide bonds present on the conjugates with the
release of the respective coumarin dyes. Nevertheless, consider-
ing the time scale, and seen the very high fluorescence efficacy
of Dye1-CO2H, Dye2-CO2H and corresponding coumarin inter-
mediates 5–10 compared to the emission of the conjugates
(fluorescence almost entirely quenched in the hybrid molecule),
we can conclude that the coumarin-organometallic conjugates
present high stability in the conditions used for this experi-
ment.
Biological activity of the coumarin conjugates against
Toxoplasma gondii
Toxoplasmosis, one of the most common global zoonotic
diseases, is caused by the protozoan parasite T. gondii.[59] This
parasite can infect virtually all warm-blooded animals on the
planet and has very high zoonotic potential. Up to one third of
the human population is infected with T. gondii, but only a
small fraction of infected individuals exhibits clinical signs. The
economic impact of T. gondii is enormous, in that it causes
severe losses in a wide range of wild and domestic animals,
including most animals used in food production. In general, T.
gondii infestation remains without clinical symptoms in immune
Figure 6. UV/Vis absorption (left) and emission (right) spectra of tricoumarin ester conjugate 22 at various concentrations in CHCl3.
Figure 7. UV/Vis absorption (left) and emission (right) spectra of the trithiolato ruthenium(II)·p-cymene complex 14b after 0 h, 24 h, 48 h, and one week
(168 h) of exposure to indoor light at 10 μM in EtOH.
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competent individuals, and no treatment is required. However,
in humans, infection has been linked to neuropsychiatric
disease, and upon immunosuppression, or primary infection
during pregnancy, T. gondii can cause toxoplasmosis, a life-
threatening disease affecting both humans and animals that
can lead to severe pathology including fetal malformation and
abortion.[60] Current standard treatment options for toxoplasmo-
sis include macrolide antibiotics and sulfonamides,[61] which
inhibit protein biosynthesis and intermediary metabolism in the
apicoplast, a prokaryote-like organelle that is unique to
apicomplexans.[62] However, these treatments are often charac-
terized by adverse side effects and do not act in a parasiticidal
manner. The development of novel treatment options that
specifically target the parasite is therefore of prime importance.
The compounds presented in this study were screened for
biological activity in vitro against T. gondii β-gal, a transgenic
strain that constitutively expresses β-galactosidase, which is
grown in HFF monolayers. In addition, the effects on uninfected
HFF host cells were assessed. For the primary screening, cell
cultures were exposed during 3 days to 1 and 0.1 μM of each
compound (including unmodified thiolato-bridged dinuclear
ruthenium(II)·arene complexes 2a/b, 3a/b, 4a/b, coumarin-
labeled conjugates 11–17a/b, 20 and 22, free dyes Dye1-CO2H
and Dye2-CO2H, and corresponding coumarin-based intermedi-
ates). The viability of HFF cultures following drug treatments
was measured by alamarBlue assay, and the proliferation of T.
gondii was quantified by measuring β-galactosidase activity.
The results of this primary screening are presented as
percentage in relation to untreated control cultures in Table S5.
The results obtained at concentration of 0.1 and 1 μM of tested
compound for T. gondii and HFF are presented in Figure 8, in
relation to controls (CTR), namely HFF treated with 0.1% DMSO
exhibiting 100% viability, and T. gondii β-gal tachyzoites treated
with 0.1% DMSO showing 100% proliferation.
No clear structure-activity relationship could be identified.
The observed activity/cytotoxicity appeared to be the result of
an interplay of various structural parameters that influence the
cellular internalization and further interactions with biomole-
cules. The trithiolato dinuclear derivatives are mono-cationic
complexes with a substantial molecular weight (>950 g/mol).
Anchoring of hydrophobic coumarin analogues as pendant
arms on one of the thiol ligands, and the nature of the
substituents present on the other two thiols, influence the
physicochemical properties of the molecule.
Compounds 2a/2b and 3a/3b bearing one hydroxy or
amino group presented considerable activity against T. gondii
β-gal at 1 μM, but also impaired HFF cell viability. The same was
observed in the case of dihydroxy compound 19. Acid
functionalized trithiolato complexes 4a and 4b did not affect
the viability of HFF monolayers, but did also not affect
tachyzoite proliferation at 1 μM. None of the coumarin-based
intermediates 5–10 (Table S5 and Figure S8) impacted on HFF
viability or T. gondii β-gal proliferation.
The nature of the substituents on the other two thiol
ligands, hydrophobic-bulky tert-butyl versus hydrophobic-polar
trifluoromethyl, had a considerable influence in the case of the
hydroxyl derivatives 2a/2b compared to the amino analogues
3a/3b. This structural feature (tBu vs CF3) appeared to affect
the activities of the ester compounds 12a/12b and the amide
compounds 14a/14b in which the coumarin is directly
connected to the thiol ligand. In some cases, (11 vs 13, 12a vs
14a,), the amide conjugates exhibited lower antiparasitic
Figure 8. In vitro activities of all compounds at 0.1 and 1 μM on A) HFF viability and B) T. gondii β-gal tachyzoites proliferation, in relation to treatments with
0.1% DMSO. For each assay, standard deviations were calculated from triplicate experiments.
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activity compared to the esters for the same coumarin
substituent.
Dye1-CO2H -functionalized compounds 13, 15, and 16a
presented a similar cytotoxicity profile for HFF at 0.1 and 1 μM.
The introduction of the linker augmented the measured activity
against the parasite. For compounds bearing Dye2-CO2H
moieties, the introduction of a linker between the diruthenium
scaffold and the coumarin led to a substantially increased
antiparasitic activity in the case of tBu analogue 17a compared
to 14a; however, a similar effect was not observed for CF3
analogues 17b and 14b. Compounds 13, 14a and 22 are only
poorly active against T. gondii β-gal at 1 μM, and the last two
compounds did not notably affect HFF cell viability. In the series
of Dye1-CO2H functionalized ester compounds 11, 20 and 22
no noteworthy correlation between the number of coumarin
units and the measured biological activity was observed. At
1 μM, 11 displayed substantial HFF toxicity, while 20 and 22 did
not. As shown in Figure 8, Dye1-CO2H and Dye2-CO2H did not
affect viability of HFF when applied at 0.1 or 1 μM. However,
proliferation of T. gondii relative to the rate of β-galactosidase
activity was decreased following treatment with 0.1 μM of
Dye1-CO2H (53%) and Dye2-CO2H (69%; Table S5). These
results might suggest that the in vitro anti-toxoplasma activity
of these coumarin dyes may be lost due to solubility issues.
Based on this preliminary screening, 13 compounds were
selected for determination of the IC50 values against T. gondii β-
gal. These were compounds that, when applied at 1 μM,
allowed viability values for HFF at 45% or more, while they also
inhibited T. gondii proliferation by 94% or more. The results are
shown in Table 2 and Figure S8, and the respective dose–
response curves are shown in Figure S9.
The most active compound against T. gondii β-gal was 12a,
with an IC50 value of 0.105 μM. This compound was not toxic at
1 μM, but when applied at 2.5 μM it reduced HFF viability to
58%. Higher levels of HFF viability impairment were noted for
compounds 12b, 17a and especially 19 (98% reduction in HFF
viability). The difference in antiparasitic activity between
compounds 12a and 12b (IC50 values of 0.105 and 0.298 μM,
respectively) highlights the importance of the physicochemical
properties of the substituents present on the other thiol ligands,
tBu versus CF3. As shown in Table 2, unmodified hydroxy
compound 2a and amino compounds 3a and 3b, also
presented considerable antiparasitic activities (IC50 values of
0.117, 0.153, and 0.135 μM, respectively), furthermore, their
impact on HFF viability at 2.5 μM was less pronounced
compared to 17a and 19.
Three selected compounds (2a, 3a and 12a), applied at
their respective IC50 against T. gondii, were further assessed with
respect to their potential to interfere in splenocyte proliferation
in vitro. Isolated murine splenocytes from healthy mice were
stimulated with concanavalin A (ConA) to induce T-cell
proliferation or with bacterial lipopolysaccharide (LPS) to induce
B-cell proliferation, either in the presence or absence of tested
compounds 2a, 3a and 12a. Measurements of proliferation
were done using an assay that quantifies the incorporation of
5-bromo-2’-deoxy-uridine (BrdU) into the DNA of replicating
cells. As seen in Figure 9, 3a and 12a significantly interfered
with T-cell proliferative responses, which resulted in a reduction
of BrdU incorporation by 25 and 31%, respectively, whereas 2a
did not affect T-cell proliferation. Compounds 2a and 3a
significantly impacted the proliferation of B cell (only 48 and
68% BrdU incorporation, respectively, compared to the control),
whereas 12a did not exhibit significant proliferation inhibition
of antibody producing cells. Thus, 3a affected both B- and T-
cell proliferation, whereas 2a and 12a impaired the proliferative
capacity of only one type of immune cells; B cells for 2a
(humoral immunity) and T cells for 12a (cellular immunity).
A reduction in the capacity of T and B cells to respond to
external signals by proliferative responses could also indicate a
potential risk of impaired immunity. However, a reduction in
cellular proliferation does not automatically imply a reduced
metabolic activity or reduction in cellular viability. Thus, in
addition to proliferative responses of B and T cells upon LPS
and ConA stimulation, we also assessed the effects of 2a, 3a
and 12a on the viability of splenocytes employing the
alamarBlue assay, which allows, similar to what we have tested
in HFF, to quantify metabolic activity (Figure 10). Measurements
taken each hour during the first 5 h after adding the substrate
resazurin showed that none of the compounds impaired the
Table 2. IC50 values [μM] against T. gondii β-gal tachyzoite proliferation
and effects on HFF viability at 2.5 μM, for selected compounds and
pyrimethamine (as positive control).
Compound IC50
[μM]
[LS; LI][a] SE[b] HFF viability at
2.5 μM [%][c]
SD[d]
2a* 0.117 [0.098;
0.139]
0.0510 56 6
2b 0.336 [0.323;
0.35]
0.0088 72 6
3a* 0.153 [0.127;
0.185]
0.0488 51 5
3b 0.135 [0.105;
0.174]
0.0562 53 4
12a* 0.105 [0.099;
0.111]
0.0230 58 4
12b 0.298 [0.292;
0.305]
0.0051 28 1
14b 0.391 [0.351;
0.437]
0.0236 71 5
16a 0.127 [0.170;
0.095]
0.129 4 1
16b 0.735 [0.467;
1.156]
0.1155 73 7
17a 0.243 [0.190;
0.311]
0.0905 25 5
17b 0.203 [0.113;
0.366]
0.1459 54 7
19 0.115 [0.098;
0.135]
0.0447 2 4
20 0.377 [0.36;
0.39]
0.0137 71 4
pyrimethamine 0.326 [0.288;
0.396]
0.0518 99 6
[a] Values at 95% confidence interval (CI); LS (limit superior) and LI (limit
inferior) are the upper and lower limits of the CI, respectively. [b] The
standard error (SE) of the estimate represents the average distance that the
observed values fall from the regression line (T. gondii β-gal). [c] Control
HFF treated only with 0.25% DMSO exhibited 100% viability. [d] The
standard deviation of the mean of six replicate experiments (HFF). Asterisks
indicate the three compounds selected for assessment of their potential to
interfere in splenocyte proliferation in vitro.
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metabolic activity of ConA-stimulated T cells, but compounds
2a and 3a significantly impaired the viability of B cells upon
stimulation with LPS. 12a did not show any interference in the
metabolic activity of either B or T cells. The lack of viability
impairment of splenocytes due to exposure with 12a observed
here indicates that this compound is a promising drug
candidate for future in vivo studies in the mouse model, to
combat T. gondii infection without impairing the cellular and
humoral immune response.
The ultrastructural changes induced by compounds 12a
(IC50 of 0.105 μM against T. gondii, HFF viability of 58% at
2.5 μM) and 17a (IC50 of 0.243 μM against T. gondii, HFF viability
of 24% at 2.5 μM) were further studied by TEM. HFF monolayers
were infected with T. gondii β-gal tachyzoites and after 24 h of
drug treatment (500 nM of each compound, a concentration
that did not notably affect the host cell) were initiated. Samples
were fixed and processed after 6, 24, and 48 h. Untreated
control cultures are shown in Figure 11. Part A shows a sample
fixed 6 h post-invasion, B and C were fixed 36 and 60 h post-
invasion, respectively, and the increase in number of parasites
illustrates the proliferation that takes place within the host cell.
Once invaded, T. gondii tachyzoites are localized within a
parasitophorous vacuole (PV), surrounded by a parasitophorous
vacuole membrane (PVM), which is essentially derived from
host cell-surface membrane modified by the parasite following
invasion. The mitochondrion exhibits a characteristic electron-
dense matrix containing numerous cristae. Tachyzoites treated
with 500 nM 12a are shown in Figure 12. At 6 h after initiation
of treatment, parasites do not exhibit massive alterations,
however, PVs usually contained only 1–3 tachyzoites. The PVM
was still clearly discernible, and the secretory organelles such as
rhoptries, micronemes, and dense granules, as well as the
mitochondria remained largely unaltered (Figure 12A, B). At
24 h, first ultrastructural changes were noted within the
mitochondrial matrix, which started to lose its characteristic
electron-dense matrix. These mitochondrial alterations became
progressively more pronounced at 24 (Figure 12D and E) and
48 h (Figure 12F, G), resulting in tachyzoites that were
completely devoid of a mitochondrion, but exhibited large,
seemingly empty, vacuoles instead. Although it is not clear
whether these effects were reversible, it is conceivable that this
extensive vacuolization would eventually lead to parasite death.
Similar results were seen for 17a, (Figure S10), although the
effects after 24 and 48 h were slightly less pronounced. Overall,
these findings mirror previously reported structural alterations
induced by ruthenium complexes reported in T. gondii, N.
caninum and in T. brucei, and in the latter it was recently shown
that active complexes strongly impaired the mitochondrial
membrane potential;[23–25] this indicates that ruthenium com-
plexes interfere in the energy metabolism of these parasites.
However, although oxidative phosphorylation resulting in the
generation of ATP is the major function of mitochondria, these
organelles are also involved in other crucial processes, including
cell-cycle regulation, tRNA and protein import, mitochondrial
protein translation, alternative oxidase, acetate production for
cytosolic and mitochondrial fatty acid biosynthesis, amino acid
metabolism, and calcium homeostasis, they are also involved in
the steps leading to programmed cell death. How, and to what
extent, these compounds actually target mitochondrial func-
tions or whether other targets are also involved remain to be
elucidated
In order to assess the potential use of the new conjugates
coumarin–diruthenium unit as cellular trackable probes
fluorescence microscopy assays were performed of HFF cells
treated with either 20 μM Dye2-CO2H or 20 μM of 12a, both
counterstained with an antibody directed against tubulin and
NucRed, a fluorescent nuclear label (see Results and Experimen-
tal in the Supporting Information). However, whereas antitubu-
lin readily stained the cytoskeleton of HFF and NucRed
indicated the nucleus, no labeling could be observed with
either Dye2-CO2H or 12a. In order to obtain trithiolato dinuclear
ruthenium conjugates suitable to be used as theranostics, the
attachment of other fluorophores should be considered.
Figure 9. Inhibitory effect of selected compounds 2a, 3a and 12a on A) ConA- and B) LPS-induced proliferative activity of mouse splenocytes. Bars represent
standard deviation from the mean of four replicates. 100% proliferation is attributed to the control (ConA or LPS); values are percentage proliferation
compared to control, *p <0.01 in relation to controls.
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Conclusion
A library of 13 new trithiolato-bridged dinuclear ruthenium
(II)·arene organometallic conjugates in which coumarin moieties
were anchored to the bridged thiol(s), has been designed and
synthesized.
Irrespective to the structural variations considered, for all
conjugates organometallic unit: coumarin an almost complete
loss of fluorescence efficacy was observed. However, the nature
of the fluorophore, the type of bonding, the presence and
length of a linker between the coumarin dye and the dinuclear
ruthenium(II) moiety, and the number of dye units influenced
the biological properties of these compounds. These modifica-
tions also affect the toxicity of these compounds against human
fibroblasts, and impact the activity against the apicomplexan
parasite T. gondii, grown in these cells in vitro. For selected
compounds (2a, 3a and 12a), applied at their T. gondii-IC50, the
effect on the proliferative responses of splenocytes upon ConA
(for T cell) and LPS (for B cell) stimulation was investigated, and
the influence on the viability/metabolic activity of B and T cells
in vitro was assessed. That the IC50 values range from 105 to
735 nM and nine compounds displayed lower IC50 values than
Figure 10. Determination of cytotoxic effects of 2a, 3a and 12a in A) ConA- and B) LPS-induced splenocytes by alamarBlue assay. Bars represent the mean
emission of four replicates � standard deviation. In both experiments and for each time point, 100% metabolic activity was attributed to the control sample
(splenocytes induced with ConA or LPS), then the percentage of metabolic activity in relation to the controls was calculated, and is indicated in the graph for
each sample. Significance with p <0.001 was observed between LPS and LPS+2a, and LPS+3a for all five time points.
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the standard drug pyrimethamine suggests that these class of
compounds is promising. In particular, compound 12a did not
affect the metabolic activity of B or T cells in vitro, is therefore
not expected to impair immunity, and thus represents a
promising compound for future in vivo assessment in toxoplas-
mosis mouse models.
Experimental Section
General: The chemistry experimental part, with full description of
experimental procedures and characterization data for all com-
pounds, is presented in the Supporting Information.
Crystal-structure determination: A crystal of C39H45Cl3O3Ru2S3 was
mounted in air at ambient conditions. All measurements were
made on a RIGAKU Synergy S area-detector diffractometer[63] using
mirror optics monochromated CuKα radiation (λ=1.54184 Å).
[64] The
unit cell constants and an orientation matrix for data collection
were obtained from a least-squares refinement of the setting angles
of reflections in the range 6.266°<2θ<155.814°. A total of 4310
frames were collected by using ω scans, with 0.05 s exposure time,
a rotation angle of 0.5° per frame, a crystal-detector distance of
31.0 mm, at T=173(2) K.
Data reduction was performed using the CrysAlisPro[63] program.
The intensities were corrected for Lorentz and polarization effects,
and an absorption correction based on the multiscan method by
using SCALE3 ABSPACK in CrysAlisPro[63] was applied. Data
collection and refinement parameters are given in Table S1.
The structure was solved by direct methods using SHELXT,[65] which
revealed the positions of all non-hydrogen atoms of the title
compound. All non-hydrogen atoms were refined anisotropically.
H-atoms were assigned in geometrically calculated positions and
refined using a riding model where each H-atom was assigned a
fixed isotropic displacement parameter with a value equal to
1.5Ueq of its parent atom (for methyl groups.
Refinement of the structure was carried out on F2 using full-matrix
least-squares procedures, which minimized the function Σw
(Fo
2  Fc
2)2. The weighting scheme was based on counting statistics
and included a factor to down weight the intense reflections. All
calculations were performed using the SHELXL-2014/7[66] program
in OLEX2.[67]
Photophysical measurements: UV/Vis spectra were recorded on a
Thermo Scientific Evolution 201 UV/Vis spectrophotometer.
Fluorescence emission spectra were measured on an Agilent Cary
Eclipse fluorescence spectrophotometer.
The UV/Vis absorption spectra of compounds 5–17a/b, 20 and 22
were recorded in the range 200–1100 nm at room temperature by
using solutions of 1, 2, 5 and 10 μM in CHCl3 and in EtOH. Emission
Figure 11. TEM of untreated T. gondii-β-gal tachyzoites fixed at A) 6, B) 24,
and C) 48 h post infection. (A) shows a single tachyzoite, located within a PV
that is delineated by a PVM (arrows). (B) Proliferation of tachyzoites takes
place within the vacuole, which occupies a substantial part of the host-cell
cytoplasm. (C) shows two neighboring PVs, delineated by arrows, located
within a HFF host cell, both containing numerous newly formed tachyzoites.
Note the mitochondrion (mito) with an electron dense matrix in (A);
nuc= tachyzoite nucleus, dg=dense granule, hcc=host cell cytoplasm;
hcn=host cell nucleus.
Figure 12. TEM of T. gondii-β-gal tachyzoites treated with 500 nM of 12a for
A), B) 6, C)–E) 24, and F)–H) 48 h. No alterations (A) or only very slight
changes in the electron dense mitochondrial matrix (mito in (B)) are
detected after 6 h. (C)–(E) show that alterations were much more
pronounced after 24 h of treatment; (C) is a low-magnification overview, (D)
and (E) represent distinct parts of (C) shown at higher magnification. (F) is a
low-magnification view of a PV of tachyzoites treated for 48 h, (G) and (H)
are high magnifications. Note the increased vacuolization (marked with *)
and the absence of any mitochondrial matrix after 24–48 h of treatment.
con=conoid; rop= rhoptries; mic=microneme; arrows point towards the
PVM.
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spectra were recorded in the range 405–650 nm after excitation at
405 nm (excitation and emission filters: auto, excitation and
emission slit=2.5 nm), using 1, 2, 5 and 10 μM solutions in CHCl3
and in EtOH. All the experiments were studied at r.t., the solvent
absorption was deducted as background.
Determination of quantum yields: Relative quantum yields for
solutions in CHCl3 and EtOH at rt were calculated by a relative
method according to Equation (1) and rhodamine 6G (ΦF=0.75 in
CHCl3, ΦF=0.94 in EtOH) as standard.
[58,68] The absorption of
rhodamine 6G was adjusted to the same value (abs <1) as that of
fluorescent molecules. Excitation was chosen at 405 nm; the
emission spectra were corrected and integrated for the area under
the emission curve.
FF xð Þ ¼
As
Ax
�
Fx
Fs
�
nx
ns
� �2
�FF sð Þ (1)
where A is the absorbance at the excitation wavelength, F is the
integration of emission intensity, n is the refractive index of the
solvents (at 20 °C) used in measurements (n=1.446 for CHCl3, n=
1.3611 for EtOH), and the subscripts s and x represent standard and
unknown, respectively.
Dl ¼ lemmax  l
abs
max (2)
Stokes shifts were calculated from Equation (2) as the difference
between the values of maxima of the intense bands in the
fluorescence and absorption spectra
Experimental biology
In vitro culture of parasites and host cells: If not stated otherwise, all
tissue culture media were purchased from Gibco-BRL, and bio-
chemical reagents were from Sigma-Aldrich). Human foreskin
fibroblasts (HFF) were maintained in DMEM containing 10% fetal
calf serum (FCS; Gibco-BRL) and antibiotics as described earlier.[10] T.
gondii β-gal (transgenic T. gondii RH expressing the β-galactosidase
gene from E. coli[69] were maintained in HFF cells, and were isolated
and separated from their host cells as described.[10]
In vitro assessment of drug efficacy: To study the effects of
compounds against T. gondii tachyzoites in vitro, 1 mM stock
solutions of complexes were prepared in DMSO, and stored at
  20 °C. For assessment of drug efficacy against T. gondii tachy-
zoites, parasites were isolated and assays were performed using
HFF as host cells as previously described.[10] In short, 5×103 HFF
cells per well were grown to confluence in a 96-well plate in
phenol-red free culture medium at 37 °C with 5% CO2. Cultures
were infected with freshly isolated T. gondii β-gal tachyzoites (1×
103 per well), and drugs were added concomitantly with infection.
Initial assessments of drug efficacy were done by exposing parasite
cultures to 0.1 and 1 μM of each compound for a period of three
days, or 0.1% DMSO was added as a control. For IC50 determi-
nations, compounds were added at 6 concentrations: 0.03, 0.06,
0.12, 0.25, 0.5, and 1 μM. After three days of incubation at 37 °C, 5%
CO2, medium was removed, and cell cultures were permeabilized
by using 90 μL PBS containing 0.05% Triton-X-100. After addition of
10 μL of 5 mM chlorophenol red-β-d-galactopyranoside (CPRG;
Roche Diagnostics) dissolved in PBS, the absorption shift was
measured at 570 nm wavelength at various time points on a
VersaMax multiplate reader (Bucher Biotec, Basel, Switzerland). For
the initial screening at 0.1 and 1 μM, the activity, measured as the
release of chlorophenol red over time, was calculated as percentage
from DMSO control, which represented 100% of T. gondii β-gal
growth. For the IC50 assays, the activity measured as the release of
chlorophenol red over time was proportional to the number of live
parasites down to 50 per well as determined in pilot assays. IC50
values were calculated after the logit-log-transformation of relative
growth and subsequent regression analysis. All calculations were
performed using the corresponding software tool contained in the
Excel software package (Microsoft).
Cytotoxicity assays on uninfected confluent HFF were performed
also in 96 well plates by exposing HFF to a concentration range of
0.1, 1, and 2.5 μM of each compound, and assessment of the
viability by alamarBlue assay as described.[70]
Isolation of murine splenocytes: Female BALB/c mice were
purchased from Charles River Laboratories (Sulzfeld, Germany) and
were maintained in a common room under controlled temperature
and a 14 h dark/10 h light cycle according to the standards set up
by the animal welfare legislation of the Swiss Veterinary Office. The
experimental protocol was approved by the Commission for Animal
Experimentation of the Canton of Bern, Switzerland (Animal license
no. BE101/17). Mice were euthanized with isoflurane and CO2, and
spleens were aseptically removed from euthanized mice. Single-cell
suspension was prepared by gently mincing spleen tissue and
passing it through sterile 40 μm cell-strainer. Erythrocytes were
depleted from cell suspension using RBC lysis buffer (Invitrogen,
Thermo Fisher Scientific) for 5 min. The viability of isolated cells was
determined using Trypan Blue dye exclusion test, and preparations
were only used when >99% of viable cell were counted.in a
Neubauer hemocytometer. The spleen cell preparation containing T
cells, dendritic cells, B cells and macrophages, was then suspended
in RPMI 1640 medium including 10% FCS, 0.05 mM 2-mercaptoe-
thanol, 2 mM l-glutamine, and 100 U of penicillin plus 50 mg of
streptomycin per mL. Cell suspensions were distributed in poly-
styrene 96 well flat bottom sterile plastic plates (Greiner Bio-One;
HuberLab) at 2×105 cells/100 μL/well.
Splenocyte proliferation assay: Isolated primary splenocytes were
either left unstimulated or were stimulated with ConA (5 μg/mL),
lipopolysaccharide (LPS, 10 μg/mL), ConA plus compound or LPS
plus compound. Compounds 2a, 3a and 12a were added at their
respective IC50 value. Experiments were performed in quadruplicate
wells, 200 μL/well, and cultures were maintained in a 37 °C
humidified chamber containing 5% CO2 for a total incubation
period of 72 h. Proliferative responses of splenocytes were meas-
ured using a BrdU cell proliferation kit (QIA58, Merck Millipore).
Briefly, BrdU label was added to the cultures 18 h prior the end of
the incubation period. Incorporated BrdU into the newly synthe-
tized DNA was measured by ELISA using anti-BrdU monoclonal
antibody. Immediately after stopping the reaction, the absorbance
was measured at 450/540 nm, in an EnSpire multilabel reader
(Perkin Elmer, Waltham). Data are presented as mean�SD for the
indicated numbers. Data comparisons between groups were
examined using a student’s t-test (significant when p <0.01).
Determination of cytotoxic effects in splenocytes: To determine
whether compounds 2a, 3a and 12a exhibit an effect on the
metabolism of ConA- and LPS-induced splenocytes, the alamarBlue
assay was performed. Isolated splenocytes were seeded in 96-well
plates at a density of 1×106 cells/mL with a final volume of 100 μL/
well. Cells were either left unstimulated or stimulated with ConA
(5 μg/mL), LPS (10 μg/mL), ConA plus compound or LPS plus
compound. Each compound was tested at its IC50 against T. gondii
β-gal, in quadruplicate wells at a volume of 200 μl/well. Cultures
were maintained in a 37 °C humidified chamber containing 5% CO2
for a total incubation period of 72 h. Resazurin (0.1 mg/mL) was
added, and the fluorescence intensity was measured at 530 nm
excitation wavelength and a 590 nm emission wavelength using an
EnSpire multilabel reader (Perkin Elmer). Measurements were done
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at different time points T=0, 1, 2, 3, 4, or 5 h. Differences were
calculated by subtracting T0 values from each time point. Data are
presented as mean of emission�SD for the indicated numbers.
Data comparisons between groups were examined using a
student’s t-test (significant when p <0.001).
Transmission electron microscopy: HFF (5×105 per inoculum)
grown to confluence in T-25 tissue culture flasks were infected with
105 T. gondii Me49 tachyzoites, and 500 nM of 12a or 17a were
added at 24 h post-infection. After 6, 24 or 48 h, cells were
harvested by using a cell scraper, and placed into the primary
fixation solution (2.5% glutaraldehyde in 100 mM sodium cacody-
late buffer pH 7.3) for 2 h. Specimens were then washed twice in
cacodylate buffer and were post-fixed in 2% OsO4 in cacodylate
buffer for 2 h, followed by washing in water, prestaining in
saturated uranyl acetate solution, and step wise dehydration in
ethanol. They were then embedded in Epon 812-resin, and
processed for TEM as described.[24] Specimens were viewed on a
CM12 transmission electron microscope operating at 80 kV.
Deposition number 1985451 (for C39H45Cl3O3Ru2S3 (21)) contains the
supplementary crystallographic data for this paper. These data are
provided free of charge by the joint Cambridge Crystallographic
Data Centre and Fachinformationszentrum Karlsruhe Access Struc-
tures service www.ccdc.cam.ac.uk/structures.
Abbreviations: IC50: concentration at which 50% of the tachyzoite
growth is inhibited (median inhibitory concentration, a measure of
tachyzoite inhibition). T. gondii β-gal: transgenic Toxoplasma gondii
tachyzoites constitutively expressing Escherichia coli β-galactosi-
dase, grown in HFF monolayers.
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